USING NEW NEXT GENERATION HIGH-TECHNOLOGY FOR A FAST AND RELIABLE DOASAGE OF MEDICINAL CANNABIS IN A FORM THAT DOES NOT COME AT THE EXPENSE OF YOUR HEALTH.
Promethean Biopharma is conducting a clinical trial for the purpose of testing the effectiveness of CBD in reducing mild to moderate pain, with the goal to making a sublingual CBD tablet available as an over the counter medication.
• Fast Onset: from 4 to 10 times faster than oil-based products
• Ability to Regulate Dosage -delivered in a water-based dissolvable tablet
• Up to 60% absorption rate
• Clinical Trial for over-the-counter medicine
• No THC
• Could allow reduction of harmful pain and related medication
The trial is a randomised double-blind placebo controlled parallel-arm study to evaluate the efficacy, safety and tolerability of a 150mg Sublingual Cannabinol.
Cannabinol (CBD) is a type of Cannabinoid that has shown to be safe, well tolerated and effective in the treatment of mild to moderate pain.
Medicinal use of the cannabis plant has been practiced for thousands of years.
​
Breaking news about our clinical trial has been published by leading news outlets.
https://www.youtube.com/watch?v=-Wheu3IbxqI
https://www.cannabiz.com.au/promethean-biopharma-joins-over-the-counter-cbd-race/